
**Bednarczy 2016** Bednarczyk D, Boiselle C. Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III. Xenobiotica. 2016 May 3;46(5):457-66.

**Drugbank** Knox C, Wilson M, Klinger CM, et al. DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res. 2024 Jan 5;52(D1):D1265-D1275. doi: 10.1093/nar/gkad976

**Gilibili 2017** Gilibili RR, Chatterjee S, Bagul P, Mosure KW, Murali BV, Mariappan TT, Mandlekar S, Lai Y. Coproporphyrin-I: a fluorescent, endogenous optimal probe substrate for ABCC2 (MRP2) suitable for vesicle-based MRP2 inhibition assay. Drug Metabolism and Disposition. 2017 Jun 1;45(6):604-11.

**Kimoto 2022** E Kimoto, C Costales, MA West, YA Bi, M Vourvahis, A David Rodrigues, MVS Varma (2022). Biomarker-Informed Model-Based Risk Assessment of Organic Anion Transporting Polypeptide 1B Mediated Drug-Drug Interactions. *Clin Pharmacol Ther*, Feb;111(2):404-415.

**Lai 2016** Lai Y, Mandlekar S, Shen H, Holenarsipur VK, Langish R, Rajanna P, Murugesan S, Gaud N, Selvam S, Date O, Cheng Y. Coproporphyrins in plasma and urine can be appropriate clinical biomarkers to recapitulate drug-drug interactions mediated by organic anion transporting polypeptide inhibition. Journal of Pharmacology and Experimental Therapeutics. 2016 Sep 1;358(3):397-404.

**Lou 2015** Z Luo, Y Zhang, J Gu, P Feng, Y Wang (2015). Pharmacokinetic Properties of Single- and Multiple-Dose Pitavastatin Calcium Tablets in Healthy Chinese Volunteers. *Curr Ther Res Clin Exp*, Mar 3;77:52-7.

**Meyer 2012** Meyer M, Schneckener S, Ludewig B, Kuepfer L, Lippert J. (2012). Using expression data for quantification of active processes in physiologically based pharmacokinetic modeling. *Drug Metab Dispos*. May;40(5), 892-901.

**Mochizuki 2022** T Mochizuki, Y Aoki, T Yoshikado, K Yoshida, Y Lai, H Hirabayashi, Y Yamaura, K Rockich, K Taskar, T Takashima, X Chu, MJ Zamek-Gliszczynski, J Mao, K Maeda, K Furihata, Y Sugiyama, H Kusuhara (2022). Physiologically-based pharmacokinetic model-based translation of OATP1B-mediated drug-drug interactions from coproporphyrin I to probe drugs. *Clin Transl Sci.* Jun;15(6):1519-1531. 

**Mori 2020** D Mori, E Kimoto, B Rago, Y Kondo, A King‐Ahmad, R Ramanathan, LS Wood, JG Johnson, VH Le, M Vourvahis, A David Rodrigues (2020). Dose‐dependent inhibition of OATP1B by rifampicin in healthy volunteers: comprehensive evaluation of candidate biomarkers and OATP1B probe drugs. *Clinical Pharmacology & Therapeutics*, Apr;107(4):1004-13.

**Nishimura 2003** Nishimura M, Yaguti H, Yoshitsugu H, Naito S, Satoh T. (2003). Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. *Yakugaku Zasshi.* May;123(5), 369-75.

**Prasad 2013** Prasad B, Lai Y, Lin Y, Unadkat JD (2013) Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotype. Journal of pharmaceutical sciences 102(3):787–93

**Prasad 2014** Prasad B, Evers R, Gupta A, Hop CECA, Salphati L, Shukla S, Ambudkar SV, Unadkat JD (2014) Interindividual variability in hepatic organic anion-transporting polypeptides and PGlycoprotein (ABCB1) protein expression: Quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex. Drug Metabolism and Disposition 42(1):78–88

**Takehara 2018** I Takehara, T Yoshikado, K Ishigame, D Mori, KI Furihata, N Watanabe, O Ando, K Maeda, Y Sugiyama, H Kusuhara (2018). Comparative study of the dose-dependence of OATP1B inhibition by rifampicin using probe drugs and endogenous substrates in healthy volunteers. *Pharmaceutical research*, Jul;35:1-3.

**Yoshikado 2018** Yoshikado T, Toshimoto K, Maeda K, Kusuhara H, Kimoto E, Rodrigues AD, Chiba K, Sugiyama Y. PBPK modeling of coproporphyrin I as an endogenous biomarker for drug interactions involving inhibition of hepatic OATP1B1 and OATP1B3. CPT: pharmacometrics & systems pharmacology. 2018 Nov;7(11):739-47.

**Zhang 2020** Zhang Y, Holenarsipur VK, Kandoussi H, Zeng J, Mariappan TT, Sinz M, Shen H. Detection of Weak Organic Anion–Transporting Polypeptide 1B Inhibition by Probenecid with Plasma-Based Coproporphyrin in Humans. Drug Metabolism and Disposition. 2020 Oct 1;48(10):841-8.

**Deo 2012** Deo AK, Prasad B, Balogh L, Lai Y, Unadkat JD. Interindividual variability in hepatic expression of the multidrug resistance-associated protein 2 (MRP2/ABCC2): quantification by liquid chromatography/tandem mass spectrometry. Drug metabolism and disposition: the biological fate of chemicals. 2012. 40(5):852–5
